Ventyx Biosciences Is A Clinical Stage Biopharmaceutical Company Based In Californiafounded In 2019 By Raju Mohanthe Company Specializes In Developing Innovative Oral Therapies Aimed At Treating Autoimmuneinflammatoryand Neurodegenerative Diseaseswith A Strong Foundation In Medicinal Chemistrystructural Biologyand Immunologyventyx Focuses On Creating Differentiated Small Molecule Therapeutics To Meet Significant Medical Needs The Company Has A Promising Pipeline Of Therapeutic Candidatesincluding Nlrp3 Inhibitors Like Vtx2735 And Vtx3232Which Are In Phase 2 Development For Various Inflammatory And Neurodegenerative Conditionsadditionallyventyx Is Advancing Its Inflammatory Bowel Disease Portfolio With Tamuzimodvtx002 Currently In Phase 3 Trials For Ulcerative Colitisand Vtx958A Tyk2 Inhibitor That Has Completed Phase 2 Trialsventyx Biosciences Is Committed To Efficient Drug Development Processes To Bring These Important Treatments To Patients
No conferences found for this company.
| Company Name | Vimalan Biosciences Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
